1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 

Characteristics of the patients treated for intracranial AVMs with DACT
CharacteristicsNo. (%)
Symptoms
    Hemorrhage8 (47.1)
    Seizures7 (41.2)
    Incidental2 (11.8)
Location
Hemisphere
    Frontal6 (35.3)
    Parietal2 (11.8)
    Temporal5 (29.4)
    Temporoparietal1 (5.9)
Deep brain
    Corpus callosum2 (11.8)
Cerebellum
    Hemisphere1 (5.9)
Spetzler-Martin grade
I3 (17.6)
II5 (29.4)
III6 (35.3)
IV3 (17.6)